Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioVenic is a specialized biotechnology company focused on providing comprehensive solutions for animal health and veterinary medicine. The company offers a wide range of services including animal drug discovery, veterinary biologics development, and animal breeding and genetics services. BioVenic supports the development of various therapeutic modalities such as vaccines, antibodies, and small molecules tailored specifically for companion animals, livestock, and poultry. Their expertise spans from early-stage research and target identification to clinical trial support and regulatory consulting. By leveraging advanced technologies in genomics and proteomics, BioVenic aims to accelerate the innovation of veterinary pharmaceuticals and nutritional products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioVenic.